Japanese University Finds New Drug Delivery Technology to Treat Glaucoma
This article was originally published in PharmAsia News
Japan's Gifu Medical University research team discovered a granula with a diameter of 100 nanometers that can deliver drugs to the bottom of an eye to treat diabetic retinopathy and glaucoma without injection or an oral drug. The team led by Hirofumi Takeuchi and Hideaki Hara found the non-toxic granula will dissolve inside the body in mice studies. The team hopes to conduct further research to load the granula with active drug compounds. (Click here for more - Japanese language)
You may also be interested in...
Veklury is now the first US FDA-approved treatment for COVID-19, but its limited benefits means its lifespan as a blockbuster could be short.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
Phase II results look good for one of the first-in-class product’s potential indications, C3 glomerulopathy. The product was highlighted late last year as an up-and-coming pipeline asset.